Martin Rowland
Overview
Explore the profile of Martin Rowland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bala N, Corrigan J, Ahmed B, Meyer J, Schongut M, Doshi P, et al.
Int J Pharm
. 2024 Sep;
664:124624.
PMID: 39227232
No abstract available.
2.
Bala N, Corrigan J, Meyer J, Schongut M, Doshi P, Iyer K, et al.
Int J Pharm
. 2024 May;
659:124246.
PMID: 38777305
Wet granulation, a particle size enlargement process, can significantly enhance the critical quality attributes of powders and improve the ability to form tablets in pharmaceutical manufacturing. In this study, a...
3.
Matsunami K, Meyer J, Rowland M, Dawson N, Beer T, Van Hauwermeiren D
Int J Pharm
. 2023 Oct;
646:123481.
PMID: 37805145
This work presents a granule size prediction approach applicable to diverse formulations containing new active pharmaceutical ingredients (APIs) in continuous twin-screw wet granulation. The approach consists of a surrogate selection...
4.
Trenfield S, Xu X, Goyanes A, Rowland M, Wilsdon D, Gaisford S, et al.
Int J Pharm X
. 2023 Jan;
5:100148.
PMID: 36590827
Selective laser sintering (SLS) 3D printing is a revolutionary 3D printing technology that has been found capable of creating drug products with varied release profiles by changing the laser scanning...
5.
Trenfield S, Januskaite P, Goyanes A, Wilsdon D, Rowland M, Gaisford S, et al.
Pharmaceutics
. 2022 Mar;
14(3).
PMID: 35335965
Selective laser sintering (SLS) 3D printing is capable of revolutionising pharmaceutical manufacturing, by producing amorphous solid dispersions in a one-step manufacturing process. Here, 3D-printed formulations loaded with a model BCS...
6.
Fina F, Goyanes A, Rowland M, Gaisford S, Basit A
Polymers (Basel)
. 2020 Aug;
12(8).
PMID: 32784645
Zero-order release formulations are designed to release a drug at a constant rate over a prolonged time, thus reducing systemic side effects and improving patience adherence to the therapy. Such...
7.
Trenfield S, Tan H, Goyanes A, Wilsdon D, Rowland M, Gaisford S, et al.
Int J Pharm
. 2020 Jan;
577:119066.
PMID: 31982555
Three-dimensional printing (3DP) is a revolutionary technology in pharmaceuticals, enabling the personalisation of flexible-dose drug products and 3D printed polypills (polyprintlets). A major barrier to entry of this technology is...
8.
Rowland M, Cavecchi A, Thielmann F, Kulon J, Shur J, Price R
Pharm Res
. 2018 Nov;
36(1):15.
PMID: 30478630
Purpose: To measure the charge to mass (Q/M) ratios of the impactor stage masses (ISM) from commercial Flixotide™ 250 μg Evohaler, containing fluticasone propionate (FP), Serevent™ 25 μg Evohaler, containing...
9.
Trenfield S, Goyanes A, Telford R, Wilsdon D, Rowland M, Gaisford S, et al.
Int J Pharm
. 2018 Aug;
549(1-2):283-292.
PMID: 30077760
Three-dimensional printing (3DP) has the potential to cause a paradigm shift in the manufacture of pharmaceuticals, enabling personalised medicines to be produced on-demand. To facilitate integration into healthcare, non-destructive characterisation...
10.
Naik S, Hancock B, Abramov Y, Yu W, Rowland M, Huang Z, et al.
J Pharm Sci
. 2016 Feb;
105(4):1467-77.
PMID: 26921122
Pharmaceutical powders are very prone to electrostatic charging by colliding and sliding contacts. In pharmaceutical formulation processes, particle charging is often a nuisance and can cause problems in the manufacture...